The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Cardiovascular disease - Primary Care

Friday, 23 February 2018
This useful wall chart shows how just 5-10% weight loss improves important markers of cardiovascular health, including lipids, blood pressure, diabetes risk and inflammation.
Category: Back to Basics
Wednesday, 21 February 2018
This article seeks to demonstrate the close relationship between cardiovascular disease and chronic kidney disease (CKD). It also highlights the importance of identifying people with CKD as a means of recognising people at high risk of both cardiovascular events and unplanned admissions.
Category: Editorial
Wednesday, 21 February 2018
 Approaches to the prevention of cardiovascular disease should be tailored to each individual. But almost everyone will benefit from lifestyle interventions that have been shown to reduce cardiovascular risk.
Category: Editorial
Tuesday, 23 January 2018
Erectile dysfunction (ED) is an important marker of subclinical cardiovascular disease, according to a new study from the US. A systematic review and meta-analysis of 28 studies, was designed to assess whether ED could be a simple and effective CV disease risk stratification tool.
Tuesday, 23 January 2018
A review of guidelines on the use of statins for primary prevention suggest that US, Canadian and UK guidelines, which recommend lower thresholds for people to receive statins, are more effective than European recommendations.
Thursday, 04 October 2018
People that sleep for more than 8 hours a night have a greater mortality and cardiovascular risk than those who sleep for under seven hours, according to a recent systematic review published in the Journal of the American Heart Association. The study also found that a sleep duration of 10 hours is linked with a 30% increased mortality risk compared to sleeping for seven hours.
Thursday, 16 August 2018
Increased physical activity, not weight loss, gives individuals with coronary heart disease (CHD) including angina and myocardial infarction a longer lifespan, according to a new long-term Norwegian study.
Tuesday, 27 February 2018
Chris Arden, Editor-in-chief of the Primary Care Cardiovascular Journal With New Year fading into the distance and the days getting longer, our attention focuses on what this year will bring in cardiovascular disease and diabetes.
Wednesday, 06 December 2017
Percutaneous coronary intervention (PCI) is not significantly better than a placebo procedure in improving exercise capacity or symptoms even in patients with severe coronary stenosis, according to new UK research. The ORBITA study is the first double blind randomised controlled trial to directly compare stenting with placebo in patients with stable angina who are receiving high quality drug treatment.
Page 1 of 2

Article search and filter